The PREVENT AGITATION Trial II - Children ≤1 Year

Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age3-12
SponsorRigshospitalet, Denmark

About this trial

Emergence agitation is a clinical condition in which the child experiences a variety of behavioural disturbances including crying, thrashing, and disorientation during early awakening from anaesthesia. Emergence agitation is a common challenge in children with a reported incidence of approximately 25% ranging from 10 to 80 %. Clonidine is often used off-label in paediatric anaesthesia e.g. sedation in the intensive care unit, prevention of withdrawal symptoms after long-term sedation, as premedication before induction of anaesthesia or as treatment/prevention of emergence agitation. The study is designed as a randomised, placebo-controlled clinical trial evaluating efficacy and safety of a single dose of intraoperative clonidine in children 3-12 months, including pharmacokinetics.

Eligibility criteria

Qualifiers

Paediatric patients (male and female), aged 3- ≤ 12 months

Scheduled general anaesthesia with sevoflurane and opioid. Induction with propofol is optional

The legally acceptable representative for the study participant provides written informed consent/assent for the trial

Disqualifiers

ASA >2

Cardiac, neuro and trauma surgery

Ex-premature (<37 weeks) • Premedication with clonidine

Intubated prior to scheduled anaesthesia or is expected to require intubation after the procedure

Trial design

Treatments tested in this trial

  • Clonidine
  • Sodium chloride

Treatment groups

336 Participants
are divided into 2 treatment groups

Sponsors and collaborators